Denis Galimzyanov wins, Tour of Beijing 2011, stage five

Russian rider Denis Galimzyanov has published a hand-written open letter admitting that he knowingly took banned blood booster erythropoietin (EPO).

The letter, published on Galimzyanov's Facebook page on Tuesday, came in reaction to Monday's announcement by the Union Cycliste Internationale (UCI) that he had failed an out-of-competition test for EPO on March 22, 2012.

Galimzyanov, 25, has stressed in his note that he acted without his Katusha team's knowledge and that he will not be requesting that his B sample be tested.

"I recognize a fact of banned substance usage," wrote Galimzyanov. "I fully realised what I did. I deeply regret about what happened, and I apologise to the whole team and my teammates, along with my fans whom I disappointed. I am ready to suffer an appropriate punishment."

"I would like to draw A PARTICULAR ATTENTION for that fact that Katusha Team has nothing to do with what happened," he continued. "No team member knew and could know about what I did. It was my personal decision and my responsibility. I refuse from my right to request and attend the analysis of my B sample."

Galimzyanov will now face a two-year suspension from competition and will likely be sacked from the Katusha team.

In March, Katusha re-signed Russian rider Alexandr Kolobnev after he had been cleared of wrong-doing after testing positive for hydrochlorothiazide at the 2011 Tour de France.

Related links

Galimzyanov tests positive for EPO

Kolobnev offered new contract with Katusha

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Nigel Wynn
Former Associate Editor

Nigel Wynn worked as associate editor on, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.